Why it matters for patients

In 2018, ECPC launched the first ever Personalised Medicine Awareness Month with the goal of raising awareness of, and increasing access to, molecular and biomarker testing in cancer care across Europe. ECPC and our member organisations believe that people living with cancer should be informed about all available treatment options and be empowered to make the best decisions for their health, together with their healthcare team. That’s why ECPC is working towards ensuring all Europeans with cancer and at risk of getting cancer have appropriate access to cancer molecular testing. This will help to promote better diagnosis, more targeted follow-up and a truly personalised treatment. We need governments to ensure the means to identify people who may benefit from more effective targeted cancer treatment, and avoid treatment-related toxicity where possible, all whilst helping to ensure the sustainability of our healthcare systems.

“Molecular testing allows a doctor to personalise cancer care for patients, identifying the right treatment for the right patient at the right time. In some countries molecular testing is not reimbursed or available to all people with cancer. This needs to change.’’

What ECPC adds

Throughout the month of November, ECPC will promote the importance of access to cancer molecular testing during a campaign – ‘Cracking the Cancer Code’. Join us and help us raise awareness and promote the right for all cancer patients to have access to the personalised medicine they need and deserve.

ECPC has developed a guide to help our member patient organisations and all supporters to participate in the Personalised Medicine Awareness Month campaign and make the most of the tools and materials. Whether you are a patient organisation, healthcare professional, patient or friend, you can find different ways to help us promote the campaign and raise awareness in your country!